- Pharm.D., University of Florida
- B.S. in Pharmacy, University of Florida
Dr. Larry Lopez joined the faculty of the University of Florida College of Pharmacy in September, 1979, after completing requirements for his post-baccalaureate Doctor of Pharmacy degree. Before accepting the faculty appointment he had worked as a community pharmacist and a hospital pharmacist for nearly 10 years. He received his high school diploma in 1964 from Jesuit High School in Tampa, Florida and his Bachelor of Science in Pharmacy from the University of Florida College of Pharmacy in 1969. Dr. Lopez retired from the faculty on November 30, 2011, after 32 years of service.
While a member of the faculty Dr. Lopez was responsible for teaching a number of topics related to the pharmacotherapy of both general internal medicine and cardiovascular disorders for the Colleges of Pharmacy and Medicine. He also maintained clinical practices in Internal Medicine and Anticoagulation at Shands at the University of Florida for the last 10 years of his appointment. Dr. Lopez served as Chairman of the Department of Pharmacy Practice from January, 1997 until July, 2002, Associate Chair of the same department from July, 2002, until July, 2011, when he once again assumed the position of Department Chairman until his retirement later that year.
Dr. Lopez’s research revolved primarily around clinical evaluations of new therapeutic modalities for management of hypertension, myocardial ischemia and/or congestive heart failure. He received over 30 grants and contracts for support of his work in these areas and published approximately 130 abstracts, articles, monographs, and chapters on these and other topics as well. Dr. Lopez was recognized for his research accomplishments by being named as a Fellow of the American College of Clinical Pharmacy and the American Society of Hypertension. He was Board Certified as a Pharmacotherapy Specialist in October, 2004.
- American College of Clinical Pharmacy
- North Central Florida Society of Health-System Pharmacists
- American Heart Association
- Florida Society of Health-System Pharmacists
- Board of Pharmaceutical Specialties
- Rational drug therapy of hypertension, ischemic heart disease, and congestive heart failure.
- Relationships between pharmacokinetics and pharmacodynamics of agents used for management of hypertension, myocardial ischemia, and congestive heart failure.
- Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice.
- Increased cardiovascular risk with second-generation antipsychotic agent switches.
- The wild ride: cardiology and clinical pharmacy 1967-2005.
- Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.
- Depressive symptoms in coronary artery disease patients after hypertension treatment.
- Rosuvastatin: a high-potency HMG-CoA reductase inhibitor.
- Cholesterol: point-of-care testing.
- Home blood pressure monitoring: point-of-care testing.
- Clinical challenges of bleeding in percutaneous coronary intervention.
- Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
Full Publication List via PubMed RSS feed